EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chemical biology and pharmacology of histone lysine methylation inhibitors

Samir H Barghout, Raquel Arminda Carvalho Machado, Dalia Barsyte-Lovejoy

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2022-08 · 1865 (6) · 194840

DOI: 10.1016/j.bbagrm.2022.194840 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2022-08. Verfasst von Samir H Barghout und 2 weiteren Autor:innen. Beteiligte Einrichtung: Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada; Department of Pharmacology & Toxicology, Faculty of Medicine, University …. Hauptthemen laut MEDLINE: Histones, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 355 Literaturangaben. Gefördert von: Pfizer, Genentech, Ontario Genomics Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone lysine methylation is a post-translational modification that plays a key role in the epigenetic regulation of a broad spectrum of biological processes. Moreover, the dysregulation of histone lysine methyltransferases (KMTs) has been implicated in the pathogenesis of several diseases particularly cancer. Due to their pathobiological importance, KMTs have garnered immense attention over the last decade as attractive therapeutic targets. These endeavors have culminated in tens of chemical probes that have been used to interrogate many aspects of histone lysine methylation. Besides, over a dozen inhibitors have been advanced to clinical trials, including the EZH2 inhibitor tazemetostat approved for the treatment of follicular lymphoma and advanced epithelioid sarcoma. In this Review, we highlight the chemical biology and pharmacology of KMT inhibitors and targeted protein degraders focusing on the clinical development of EZH1/2, DOT1L, Menin-MLL, and WDR5-MLL inhibitors. We also briefly discuss the pharmacologic targeting of other KMTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesNeoplasmsBiologyEpigenesis, GeneticHumansIntracellular Signaling Peptides and ProteinsLysineMethylationProtein Processing, Post-Translational

Stichwörter der Autor:innen

DOT1LEZH2G9a/GLPHistone MethyltransferaseMenin-MLLNSDPRC2SETD7SETD8SUV420H1/2WDR5-MLL

Substanzen

HistonesIntracellular Signaling Peptides and ProteinsWDR5 protein, humanLysine

Autor:innen und Institutionen

  • Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada; Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Pharmacology & Toxicolo…
  • Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada; Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada; Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: d.barsyte@utoront…

Förderung

  • Pfizer
  • Genentech
  • Ontario Genomics Institute
  • Mitacs
  • Natural Sciences and Engineering Research Council of Canada
  • McGill University
  • Janssen Pharmaceuticals
  • Innovative Medicines Initiative

Zitieren

APA

Barghout, S. H., Machado, R. A. C., & Barsyte-Lovejoy, D. (2022). Chemical biology and pharmacology of histone lysine methylation inhibitors. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1865(6), 194840. https://doi.org/10.1016/j.bbagrm.2022.194840

Vancouver

Barghout SH, Machado RAC, Barsyte-Lovejoy D. Chemical biology and pharmacology of histone lysine methylation inhibitors. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2022;1865(6):194840. doi:10.1016/j.bbagrm.2022.194840

BibTeX
@article{Barghout2022,
  author = {Barghout, Samir H and Machado, Raquel Arminda Carvalho and Barsyte-Lovejoy, Dalia},
  title = {Chemical biology and pharmacology of histone lysine methylation inhibitors},
  journal = {Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms},
  year = {2022},
  volume = {1865},
  number = {6},
  pages = {194840},
  doi = {10.1016/j.bbagrm.2022.194840}
}
Kostenlos starten →